Cited by 351Autophagy in Disease and TherapyUbiquitin and proteasome pathwaysAlzheimer's disease research and treatments

Autophagy and the ubiquitin-proteasome system: Collaborators in neuroprotection

Open access
Nedelsky, Natalia B., Todd, Peter K., Taylor, J. Paul·2008·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Abstract

Protein degradation is an essential cellular function that, when dysregulated or impaired, can lead to a wide variety of disease states. The two major intracellular protein degradation systems are the ubiquitin-proteasome system (UPS) and autophagy, a catabolic process that involves delivery of cellular components to the lysosome for degradation. While the UPS has garnered much attention as it relates to neurodegenerative disease, important links between autophagy and neurodegeneration have also become evident. Furthermore, recent studies have revealed interaction between the UPS and autophagy, suggesting a coordinated and complementary relationship between these degradation systems that becomes critical in times of cellular stress. Here we describe autophagy and review evidence implicating this system as an important player in the pathogenesis of neurodegenerative disease. We discuss the role of autophagy in neurodegeneration and review its neuroprotective functions as revealed by experimental manipulation in disease models. Finally, we explore potential parallels and connections between autophagy and the UPS, highlighting their collaborative roles in protecting against neurodegenerative disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2008.10.002

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Abundant accumulation of autophagic vacuoles in swollen neurons is linked with Aβ/APP-βCTF, suggesting that autophagy clearance is severely disrupted under pathological conditions and is closely linked to amyloid pathology.

    “However, the abundant accumulation of autophagic vacuoles in swollen (malnourished) neurons is observed to have a linkage with Aβ/APP-βCTF, suggesting that autophagy clearance is severely disrupted under pathological conditions and is closely linked to amyloid pathology.115,225,230”

    From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [225]

    The section on increased autophagic vacuoles describes their massive accumulation in swollen, degenerating neurites in Alzheimer’s disease, but says that this observation alone cannot establish whether autophagic clearance is impaired. The section on animal models reports evidence of impaired autophagosome–lysosome fusion and links APP turnover to toxic amyloid-β; it does not mention APP-βCTF or establish that clearance is severely disrupted. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 103 · Cited by 351

Authors
Nedelsky, N. B., Todd, P. K., & Taylor, J. P.
Affiliations
  • University of Pennsylvania (US)
  • University of Michigan (US)
  • St. Jude Children's Research Hospital (US)
Corresponding author
Taylor, J. Paul
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2008-12
Volume
1782
Issue
12
Pages
691-699
ISSN
0925-4439 (ISSN-L)
OpenAlex
W2120180072
Cited by
351
References
103
Citations by year
2026: 8 · 2025: 13 · 2024: 12 · 2023: 21 · 2022: 16 · 2021: 26 · 2020: 21 · 2019: 19 · 2018: 22 · 2017: 21 · 2016: 20 · 2015: 19 · 2014: 31 · 2013: 15 · 2012: 22
FWCI
2.32
Type
journal article
Language
en
Open access
Locations
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Funders
  • Muscular Dystrophy Association
  • National Institutes of Health
  • National Institute on Aging (R01AG031587)
  • National Institute of Neurological Disorders and Stroke (R01NS053825, NS053825)
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
autophagy, ubiquitin-proteasome system, neuroprotection, neurodegenerative diseases, protein degradation, lysosomal degradation, cellular stress, disease models
MeSH terms
Animals, Autophagy, Humans, Neuroprotective Agents, Neurodegenerative Diseases, Ubiquitin, Proteasome Endopeptidase Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review